52north Seed
5 known investors
52 North Health develops the patented Aster platform, a portable finger-prick blood test and companion app that measures cell-based and soluble biomarkers to identify immunosuppressed patients at risk of neutropenic sepsis. It also builds digital tools for remote triaging and management of emergency cancer care, working with patients and clinicians to make emergency care safer.
BiotechDigital HealthMedical Devices
Investors · 5
Frequently asked questions
- What does 52north Seed do?
- 52 North Health develops the patented Aster platform, a portable finger-prick blood test and companion app that measures cell-based and soluble biomarkers to identify immunosuppressed patients at risk of neutropenic sepsis. It also builds digital tools for remote triaging and management of emergency cancer care, working with patients and clinicians to make emergency care safer.
- Who are 52north Seed's investors?
- 52north Seed's investors include Cambridge Angels group, Future Planet Capital, Meridian Health Ventures, Parkwalk Advisors, Milltrust International Group.